TOFA (MCP Hahnemann Uni)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTOFA (MCP Hahnemann Uni)
Drug Alias Name5-(tetradecyloxy)-2-furan carboxylic acidTOFA (Allegheny)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor modulators
TargetsDopamine D1 receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMCP Hahnemann University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMCP Hahnemann University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A